Kerr Douglas
SEC CIK 1814189 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DYN | Dyne Therapeutics, Inc. | Chief Medical Off | 162.6K | — | $325.8K | 12 | 2024-09-03 | 2026-09-04 |
Most active insiders at DYN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rhodes Jason P | Dir | — | $129.10M |
| 2 | Kersten Dirk | Dir | — | $38.57M |
| 3 | Cox John | CEO, Pres, Dir | — | $443.7K |
| 4 | Posner Brian S | Dir | $274.8K | — |
| 5 | Kerr Douglas | Chief Medical Off | — | $233.1K |
| 6 | Lucera Erick | CFO | — | $228.7K |
| 7 | Friedl-Naderer Johanna | Chief Commercial Off | — | $43.4K |
| 8 | Lubner David Charles | Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-09-08 16:14 | 2026-09-04+ | DYN | Dyne Therapeutics, Inc. | Kerr Douglas | Chief Medical Off | S - Sale | $22.95 | -5,035 | 162.6K | -3% | -$115.5K |
| T | 2026-08-17 16:08 | 2026-08-13 | DYN | Dyne Therapeutics, Inc. | Kerr Douglas | Chief Medical Off | S - Sale | $26.28 | -1,556 | 167.6K | -0.9% | -$40.9K |
| T | 2026-06-17 16:08 | 2026-06-16 | DYN | Dyne Therapeutics, Inc. | Kerr Douglas | Chief Medical Off | S - Sale | $18.33 | -887 | 169.2K | -0.5% | -$16.3K |
| T | 2026-05-14 16:04 | 2026-05-13 | DYN | Dyne Therapeutics, Inc. | Kerr Douglas | Chief Medical Off | S - Sale | $18.36 | -1,564 | 170.0K | -0.9% | -$28.7K |
| T | 2026-03-06 | 2026-03-05 | DYN | Dyne Therapeutics, Inc. | Kerr Douglas | Chief Medical Off | S - Sale | $14.90 | -904 | 171.6K | -0.5% | -$13.5K |
| D | 2026-02-17 | 2026-02-12 | DYN | Dyne Therapeutics, Inc. | Kerr Douglas | Chief Medical Off | A - Grant | $0.00 | +85.0K | 172.5K | +97% | $0 |
| T | 2025-12-05 | 2025-12-05 | DYN | Dyne Therapeutics, Inc. | Kerr Douglas | Chief Medical Off | S - Sale | $20.72 | -880 | 87.5K | -1.0% | -$18.2K |
| MT | 2025-09-08 | 2025-09-04+ | DYN | Dyne Therapeutics, Inc. | Kerr Douglas | Chief Medical Off | S - Sale | $13.30 | -4,425 | 88.4K | -5% | -$58.8K |
| T | 2025-06-06 | 2025-06-05 | DYN | Dyne Therapeutics, Inc. | Kerr Douglas | Chief Medical Off | S - Sale | $13.35 | -1,342 | 92.8K | -1% | -$17.9K |
| T | 2025-03-07 | 2025-03-05 | DYN | Dyne Therapeutics, Inc. | Kerr Douglas | Chief Medical Off | S - Sale | $11.83 | -1,343 | 94.2K | -1% | -$15.9K |
| D | 2024-12-06 | 2024-12-04 | DYN | Dyne Therapeutics, Inc. | Kerr Douglas | Chief Medical Off | A - Grant | $0.00 | +48.0K | 95.5K | +101% | $0 |
| D | 2024-09-03 | 2024-09-03 | DYN | Dyne Therapeutics, Inc. | Kerr Douglas | Chief Medical Off | A - Grant | $0.00 | +47.5K | 47.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations